Good Morning (at least in my time-zone)!

I have been having some trouble with some routine Immunological staining with HRP + DAB of paraffin-embedded tissue, and I was hoping the experts here could shed some light onto this problem!

In the last batch of staining we noticed that the HRP staining was uneven on the tissue- some areas would have significant brown splotches of DAB precipitate while others did not, seemingly randomly or at least somewhat randomly, often appearing in the core of the tissue [Kidney] (Picture 1). Staining was present in the lighter areas but not as strong as in the dark areas. Staining was absent in the no primary antibody controls (the left-most tissue on each slide is a negative control- with the exception of those labeled 'bleed'). I'm concerned that the staining differences may not reflect actual phenotypes but are due to artifacts from the staining process.

In addition there are consistent weird 'lines' of DAB staining/precipitate present in the sections that appear to be artifacts of some kind (Picture 2). Lately I'm paranoid that it could be a "systemic" artifact across our IHC work as in the past some previous HRP stainings had similar irregular blotches of staining.

Our protocol is a standard HRP protocol meshed together from standard ABCam and Cell-Signaling-Technology protocols. The general gist is as follows:

1. After conclusion of animal experiment the tissue is removed, and "dropped" (drop-fixed) into a solution of 10% buffered-neutral formalin.

2. Tissue remains in fixative for approximately 6-8 days until it is sent and arrives at a third-party that does the sectioning for us.

3. Tissue is processed by the third party: standard paraffin sectioning with the tissues cut onto slides. The tissue is sent back to our facility where we then proceed with our experiments.

4. Standard Paraffin-HRP-IHC is followed, with deparaffinization (xylene + ethanol washes), microwave antigen retrieval (depending on company recommendations for the primary- in this case: EDTA), permeabilization with triton, blocking with commercial block solution, primary antibody overnight incubation, hydrogen peroxide quenching, secondary incubation, DAB incubation (with "drops" of DAB covering each tissue- the liquid remaining on the tissue due to a hydrophobic pap-pen boundary), haematoxylin counter-staining, dehydration ("reverse" deparaffinization with ethanol -> xylene), and cover-slip application- with all the washes in-between. Slides are left to cure overnight and then visualized the next morning (or carefully visualized immediately by an eager and anxious research associate).

I hope to receive any information, suggestions, leads, comments, questions, and/or thoughts you may have. I have some of my own, but I will remain quiet in the hopes that more experienced researchers than myself may know what went wrong... or what went right.

Thank you for your time and advice!

Anthony

More Anthony Undisclosed's questions See All
Similar questions and discussions